Kenoki Ohuchida

Author PubWeight™ 77.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol Cancer Ther 2009 2.41
2 MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis. Surgery 2011 2.06
3 alpha-Smooth Muscle Actin Expressing Stroma Promotes an Aggressive Tumor Biology in Pancreatic Ductal Adenocarcinoma. Pancreas 2010 1.94
4 MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation. Mol Cancer 2010 1.66
5 Intraabdominal Roux-en-Y reconstruction with a novel stapling technique after laparoscopic distal gastrectomy. Gastric Cancer 2009 1.54
6 Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy. Neoplasia 2010 1.36
7 CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer. Gastroenterology 2010 1.33
8 Effectiveness of basic endoscopic surgical skill training for pediatric surgeons. Pediatr Surg Int 2010 1.27
9 MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma. Ann Surg Oncol 2010 1.25
10 MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. Cancer Biol Ther 2010 1.17
11 Laparoscopy-assisted distal gastrectomy for early gastric cancer: is it beneficial for patients of heavier weight? Ann Surg 2003 1.11
12 Gli1 contributes to the invasiveness of pancreatic cancer through matrix metalloproteinase-9 activation. Cancer Sci 2008 1.08
13 Down-regulation of deoxycytidine kinase enhances acquired resistance to gemcitabine in pancreatic cancer. Anticancer Res 2008 1.06
14 Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells. Cancer Res 2013 1.06
15 Enhanced cell migration and invasion of CD133+ pancreatic cancer cells cocultured with pancreatic stromal cells. Cancer 2010 1.05
16 Feasibility and safety of intracorporeal esophagojejunostomy after laparoscopic total gastrectomy: inverted T-shaped anastomosis using linear staplers. Surgery 2013 1.02
17 Significance of combination therapy of zoledronic acid and gemcitabine on pancreatic cancer. Cancer Sci 2011 1.01
18 Tumor-stromal interactions with direct cell contacts enhance proliferation of human pancreatic carcinoma cells. Cancer Sci 2009 1.01
19 Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas. Hum Pathol 2010 1.00
20 Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype. Ann Surg 2013 0.98
21 Podoplanin expression in cancer-associated fibroblasts enhances tumor progression of invasive ductal carcinoma of the pancreas. Mol Cancer 2013 0.98
22 High EGFR mRNA expression is a prognostic factor for reduced survival in pancreatic cancer after gemcitabine-based adjuvant chemotherapy. Int J Oncol 2011 0.97
23 MicroRNA expression analyses in preoperative pancreatic juice samples of pancreatic ductal adenocarcinoma. JOP 2010 0.96
24 LMO2 is a novel predictive marker for a better prognosis in pancreatic cancer. Neoplasia 2009 0.96
25 Invasive carcinoma derived from the nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type. Surgery 2010 0.96
26 Overexpression of c-met in the early stage of pancreatic carcinogenesis; altered expression is not sufficient for progression from chronic pancreatitis to pancreatic cancer. World J Gastroenterol 2006 0.95
27 LIM only 4 is overexpressed in late stage pancreas cancer. Mol Cancer 2008 0.94
28 Three-dimensional high-definition neuroendoscopic surgery: a controlled comparative laboratory study with two-dimensional endoscopy and clinical application. J Neurol Surg A Cent Eur Neurosurg 2013 0.93
29 S100A4 mRNA is a diagnostic and prognostic marker in pancreatic carcinoma. J Gastrointest Surg 2009 0.93
30 Prospectively isolated cancer-associated CD10(+) fibroblasts have stronger interactions with CD133(+) colon cancer cells than with CD133(-) cancer cells. PLoS One 2010 0.92
31 S100P is a novel marker to identify intraductal papillary mucinous neoplasms. Hum Pathol 2010 0.91
32 Fascin overexpression in intraductal papillary mucinous neoplasms (adenomas, borderline neoplasms, and carcinomas) of the pancreas, correlated with increased histological grade. Mod Pathol 2007 0.90
33 Predicting the chemosensitivity of pancreatic cancer cells by quantifying the expression levels of genes associated with the metabolism of gemcitabine and 5-fluorouracil. Int J Oncol 2011 0.90
34 Co-cultivation of pancreatic cancer cells with orthotopic tumor-derived fibroblasts: fibroblasts stimulate tumor cell invasion via HGF secretion whereas cancer cells exert a minor regulative effect on fibroblasts HGF production. Cancer Lett 2003 0.90
35 Increased expression of ADAM 9 and ADAM 15 mRNA in pancreatic cancer. Anticancer Res 2007 0.90
36 TEM7 (PLXDC1) in neovascular endothelial cells of fibrovascular membranes from patients with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 2008 0.90
37 All-trans retinoic acid inhibits the cell proliferation but enhances the cell invasion through up-regulation of c-met in pancreatic cancer cells. Cancer Lett 2004 0.89
38 SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients. Anticancer Res 2010 0.89
39 Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review. Ann Surg 2014 0.88
40 Pancreatic cancer cells enhance the ability of collagen internalization during epithelial-mesenchymal transition. PLoS One 2012 0.88
41 Laparoscopic total gastrectomy for remnant gastric cancer: feasibility study. Surg Endosc 2013 0.88
42 Skills assessment using a virtual reality simulator, LapSim, after training to develop fundamental skills for endoscopic surgery. Minim Invasive Ther Allied Technol 2010 0.88
43 Single-incision laparoscopy-assisted surgery for bowel obstruction: report of three cases. Surg Today 2011 0.88
44 Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma. Ann Surg Oncol 2011 0.87
45 Suppression of metastasis of human pancreatic cancer to the liver by transportal injection of recombinant adenoviral NK4 in nude mice. Int J Cancer 2005 0.87
46 Objective assessment of the suture ligature method for the laparoscopic intestinal anastomosis model using a new computerized system. Surg Endosc 2014 0.87
47 Hypoxia enhances the interaction between pancreatic stellate cells and cancer cells via increased secretion of connective tissue growth factor. J Surg Res 2012 0.86
48 Bone marrow-derived monocyte lineage cells recruited by MIP-1β promote physiological revascularization in mouse model of oxygen-induced retinopathy. Lab Invest 2011 0.86
49 Invasive carcinoma derived from intestinal-type intraductal papillary mucinous neoplasm is associated with minimal invasion, colloid carcinoma, and less invasive behavior, leading to a better prognosis. Pancreas 2011 0.85
50 The role of the DNA damage checkpoint pathway in intraductal papillary mucinous neoplasms of the pancreas. Clin Cancer Res 2007 0.85
51 Technical feasibility of laparoscopic total gastrectomy with splenectomy for gastric cancer: clinical short-term and long-term outcomes. Surg Endosc 2014 0.85
52 Combination with low-dose gemcitabine and hTERT-promoter-dependent conditionally replicative adenovirus enhances cytotoxicity through their crosstalk mechanisms in pancreatic cancer. Cancer Lett 2010 0.84
53 Micro RNA-373 is down-regulated in pancreatic cancer and inhibits cancer cell invasion. Ann Surg Oncol 2014 0.84
54 Radiation enhances adenoviral gene therapy in pancreatic cancer via activation of cytomegalovirus promoter and increased adenovirus uptake. Clin Cancer Res 2008 0.83
55 An augmented reality navigation system for pediatric oncologic surgery based on preoperative CT and MRI images. J Pediatr Surg 2013 0.82
56 Kindlin-2 expression in peritumoral stroma is associated with poor prognosis in pancreatic ductal adenocarcinoma. Pancreas 2013 0.82
57 Kindlin-1 expression is involved in migration and invasion of pancreatic cancer. Int J Oncol 2013 0.82
58 Feasibility of laparoscopic gastrectomy for advanced gastric cancer with positive peritoneal cytology. Surg Today 2012 0.81
59 Adenoviral therapy is more effective in gemcitabine-resistant pancreatic cancer than in gemcitabine-sensitive cells. Anticancer Res 2011 0.81
60 Midkine mRNA is overexpressed in pancreatic cancer. Dig Dis Sci 2008 0.81
61 Quantitative analysis of hTERT mRNA levels in cells microdissected from cytological specimens. Cancer Sci 2008 0.81
62 Tumor-stroma interactions reduce the efficacy of adenoviral therapy through the HGF-MET pathway. Cancer Sci 2010 0.81
63 Clinical significance of GNAS mutation in intraductal papillary mucinous neoplasm of the pancreas with concomitant pancreatic ductal adenocarcinoma. Pancreas 2015 0.81
64 REG4 is associated with carcinogenesis in the 'intestinal' pathway of intraductal papillary mucinous neoplasms. Mod Pathol 2009 0.81
65 Mass spectrometry-based metabolic profiling of gemcitabine-sensitive and gemcitabine-resistant pancreatic cancer cells. Pancreas 2014 0.81
66 Augmented reality navigation system for laparoscopic splenectomy in children based on preoperative CT image using optical tracking device. Pediatr Surg Int 2011 0.81
67 Strategy for prevention of local recurrence of pancreatic cancer after pancreatectomy: antitumor effect of gemcitabine mixed with fibrin glue in an orthotopic nude mouse model. Surgery 2006 0.81
68 The risk of lymph node metastasis in mucosal gastric carcinoma: especially for a mixture of differentiated and undifferentiated adenocarcinoma. Hepatogastroenterology 2012 0.80
69 MAL2 expression predicts distant metastasis and short survival in pancreatic cancer. Surgery 2013 0.80
70 S100A4 mRNA expression level is a predictor of radioresistance of pancreatic cancer cells. Oncol Rep 2013 0.80
71 Biological evaluation of protein nanocapsules containing doxorubicin. Int J Nanomedicine 2013 0.79
72 Migratory activity of CD105+ pancreatic cancer cells is strongly enhanced by pancreatic stellate cells. Pancreas 2013 0.79
73 Liver cell specific targeting by the preS1 domain of hepatitis B virus surface antigen displayed on protein nanocages. Int J Nanomedicine 2012 0.79
74 CD271⁺ subpopulation of pancreatic stellate cells correlates with prognosis of pancreatic cancer and is regulated by interaction with cancer cells. PLoS One 2012 0.79
75 Tissue tablet method: an efficient tissue banking procedure applicable to both molecular analysis and frozen tissue microarray. Hum Pathol 2014 0.79
76 Outcomes of cervical end-to-side triangulating esophagogastric anastomosis with minimally invasive esophagectomy. World J Surg 2015 0.79
77 Design and Function of Engineered Protein Nanocages as a Drug Delivery System for Targeting Pancreatic Cancer Cells via Neuropilin-1. Mol Pharm 2015 0.79
78 Chemotherapeutic agents potentiate adenoviral gene therapy for pancreatic cancer. Cancer Sci 2009 0.78
79 hTERT-promoter-dependent oncolytic adenovirus enhances the transduction and therapeutic efficacy of replication-defective adenovirus vectors in pancreatic cancer cells. Cancer Sci 2009 0.78
80 Significance of metacognitive skills in laparoscopic surgery assessed by essential task simulation. Minim Invasive Ther Allied Technol 2013 0.78
81 CD44v6 expression in intraductal papillary mucinous neoplasms of the pancreas. Pancreas 2010 0.77
82 Inhibition of p600 expression suppresses both invasiveness and anoikis resistance of gastric cancer. Ann Surg Oncol 2011 0.77
83 Expression of claudin-4 (CLDN4) mRNA in intraductal papillary mucinous neoplasms of the pancreas. Mod Pathol 2010 0.77
84 Up-regulation of integrin beta3 in radioresistant pancreatic cancer impairs adenovirus-mediated gene therapy. Cancer Sci 2009 0.76
85 A minimally invasive and simple screening test for detection of pancreatic ductal adenocarcinoma using biomarkers in duodenal juice. Pancreas 2013 0.76
86 Expression of activation-induced cytidine deaminase in ulcerative colitis-associated carcinogenesis. Histopathology 2011 0.76
87 Insig2 is overexpressed in pancreatic cancer and its expression is induced by hypoxia. Cancer Sci 2011 0.76
88 Podoplanin expression in the cyst wall correlates with the progression of intraductal papillary mucinous neoplasm. Virchows Arch 2014 0.76
89 Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers. Pancreas 2016 0.76
90 Expression of glucagon-like Peptide 1 receptor and its effects on biologic behavior in pancreatic neuroendocrine tumors. Pancreas 2014 0.75
91 [Molecular biology-based diagnosis and therapy for pancreatic cancer]. Fukuoka Igaku Zasshi 2011 0.75
92 Senescence in intraductal papillary mucinous neoplasm of the pancreas. Hum Pathol 2011 0.75
93 S100P in Duodenal Fluid Is a Useful Diagnostic Marker for Pancreatic Ductal Adenocarcinoma. Pancreas 2017 0.75